Weiss Multi-Strategy Advisers LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 151 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 1.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$123,000
-65.2%
35,0000.0%0.01%
-44.4%
Q3 2018$353,000
+11.4%
35,000
-20.1%
0.01%
+12.5%
Q2 2018$317,000
+42.8%
43,830
+19.4%
0.01%
+14.3%
Q1 2018$222,000
-33.1%
36,700
+6.4%
0.01%
-22.2%
Q4 2017$332,000
-24.4%
34,500
-30.3%
0.01%
-43.8%
Q3 2017$439,000
-22.0%
49,500
+11.2%
0.02%
-33.3%
Q2 2017$563,000
+19.0%
44,500
-1.1%
0.02%
+26.3%
Q1 2017$473,000
+145.1%
45,000
+114.3%
0.02%
+111.1%
Q4 2016$193,000
-22.2%
21,0000.0%0.01%
-40.0%
Q3 2016$248,000
-10.8%
21,000
-2.4%
0.02%
-31.8%
Q2 2016$278,000
-42.1%
21,510
-28.3%
0.02%
+4.8%
Q1 2016$480,000
-44.1%
30,0000.0%0.02%
-64.4%
Q4 2015$859,000
-13.8%
30,000
-14.3%
0.06%
+34.1%
Q3 2015$996,000
-53.8%
35,000
-41.7%
0.04%
-48.2%
Q2 2015$2,155,000
-17.6%
60,000
+33.3%
0.08%
-26.7%
Q1 2015$2,616,000
+41.0%
45,000
+2.3%
0.12%
+81.2%
Q4 2014$1,855,000
+36.7%
44,000
+25.7%
0.06%
+93.9%
Q3 2014$1,357,000
+44.8%
35,000
+16.7%
0.03%
+65.0%
Q2 2014$937,00030,0000.02%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2015
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders